Immunological Properties of Murine Parthenogenetic Stem Cell-Derived Cardiomyocytes and Engineered Heart Muscle
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunological Properties of Murine Parthenogenetic Stem Cell-Derived Cardiomyocytes and Engineered Heart Muscle
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-08-14
DOI
10.3389/fimmu.2017.00955
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration
- (2017) Michiko Mandai et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease
- (2016) Rodolfo Gonzalez et al. CELL TRANSPLANTATION
- Beneath the sword of Damocles: regenerative medicine and the shadow of immunogenicity
- (2016) Paul J Fairchild et al. Regenerative Medicine
- Preclinical study of mouse pluripotent parthenogenetic embryonic stem cell derivatives for the construction of tissue-engineered skin equivalent
- (2016) Yang Rao et al. Stem Cell Research & Therapy
- Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson’s Disease
- (2016) Ibon Garitaonandia et al. Scientific Reports
- Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells
- (2015) Tongbiao Zhao et al. Cell Stem Cell
- Stem Cell Therapies in Clinical Trials: Progress and Challenges
- (2015) Alan Trounson et al. Cell Stem Cell
- Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction ModelNovelty and Significance
- (2015) Johannes Riegler et al. CIRCULATION RESEARCH
- Development of a global network of induced pluripotent stem cell haplobanks
- (2015) Ian Wilmut et al. Regenerative Medicine
- Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153
- (2015) Babak Baban et al. PLoS One
- Brief Report: Parthenogenetic Embryonic Stem Cells are an Effective Cell Source for Therapeutic Liver Repopulation
- (2014) Silvia Espejel et al. STEM CELLS
- Lack of Immune Response to Differentiated Cells Derived from Syngeneic Induced Pluripotent Stem Cells
- (2013) Prajna Guha et al. Cell Stem Cell
- Immunogenicity of Pluripotent Stem Cells and Their Derivatives
- (2013) Patricia E. de Almeida et al. CIRCULATION RESEARCH
- Parthenogenetic stem cells for tissue-engineered heart repair
- (2013) Michael Didié et al. JOURNAL OF CLINICAL INVESTIGATION
- Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells
- (2013) Ryoko Araki et al. NATURE
- Role of the PD-1 Pathway in the Immune Response
- (2012) L. V. Riella et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Generating an iPSC Bank for HLA-Matched Tissue Transplantation Based on Known Donor and Recipient HLA Types
- (2012) Craig J. Taylor et al. Cell Stem Cell
- PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis
- (2012) M. L. Tarrio et al. JOURNAL OF IMMUNOLOGY
- Gene therapy by allele selection in a mouse model of beta-thalassemia
- (2011) Sigrid Eckardt et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunogenicity of induced pluripotent stem cells
- (2011) Tongbiao Zhao et al. NATURE
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- Teratoma formation by human embryonic stem cells: Evaluation of essential parameters for future safety studies
- (2009) Hannes Hentze et al. Stem Cell Research
- HLA Homozygous Stem Cell Lines Derived from Human Parthenogenetic Blastocysts
- (2007) E.S. Revazova et al. Cloning Stem Cells
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started